Evidence map›Paper›PMID 26487694›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

PDIA6 regulates insulin secretion by selectively inhibiting the RIDD activity of IRE1.

Daniela Eletto, Davide Eletto, Sarah Boyle, Yair Argon

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. CaNature cell biology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniela ElettoDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Davide ElettoDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sarah BoyleDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Yair ArgonDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA yargon@mail.med.upenn.edu.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

Regulation of IGF Levels in Development and in AgingR01AG018001 · NIA · UNIVERSITY OF CHICAGO · PI ARGON, YAIR · 2000 to 2016
$5.9M
Regulation of insulin-like growth factors by the ER chaperone GRP94R01GM077480 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI ARGON, YAIR · 2010 to 2013
$1.3M
NIAID NIH HHS AI-18001NIA NIH HHS R01 AG018001NIGMS NIH HHS R01 GM077480
6 · The paper itself

Abstract

Protein disulfide isomerase A6 (PDIA6) interacts with protein kinase RNA-like endoplasmic reticulum kinase (PERK) and inositol requiring enzyme (IRE)-1 and inhibits their unfolded protein response signaling. In this study, shRNA silencing of PDIA6 expression in insulin-producing mouse cells reduced insulin production (5-fold) and, consequently, glucose-stimulated insulin secretion (3-4-fold). This inhibition of insulin release was independent of the PDIA6-PERK interaction or PERK activity. Acute inhibition of PERK did not change the short-term response of β cells to glucose. Rather, PDIA6 affected insulin secretion by modulating one of the activities of IRE1. At 11 mM glucose and lower, the regulated IRE1-dependent decay (RIDD) of the mRNA activity of IRE1 was activated, but not its X-box binding protein (XBP)-1 splicing activity. In the absence of PDIA6, RIDD activity toward insulin transcripts was enhanced up to 4-fold, as shown by molecular assays in cultured cells and the use of a fluorescent reporter in intact islets. Such physiologic activation of IRE1 by glucose contrasted with IRE1 activation by chemical stress, when both IRE1 activities were induced. Thus, whereas the stimulus determines the quality of IRE1 signaling, PDIA6 attenuates multiple enzymatic activities of IRE1, maintaining its signaling within a physiologically tolerable range.

Indexed as

ActinsAnimalsCell LineDNA-Binding ProteinseIF-2 KinaseEndoribonucleasesEnzyme InhibitorsGene SilencingGlucoseHumansInsulinInsulin SecretionIslets of LangerhansMembrane ProteinsMiceProtein Disulfide-IsomerasesActinsDNA-Binding ProteinseIF-2 KinaseEndoribonucleasesEnzyme InhibitorsERN1 protein, humanErn2 protein, mouseGlucoseInsulinMembrane ProteinsPDIA6 protein, humanPdia6 protein, mouseProtein Disulfide-IsomerasesProtein Serine-Threonine KinasesRegulatory Factor X Transcription FactorsRNA, MessengerThapsigarginTranscription FactorsX-Box Binding Protein 1XBP1 protein, humanXbp1 protein, mouseGSISunfolded protein responseβ-cell metabolism

Identifiers

PMID26487694
PMCPMC4714551
OpenAlexW2172385068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.